Circulating Tumor DNA in Early Stage and Locally Advanced NSCLC: Ready for Clinical Implementation?

0
98
Researchers summarize the increasing evidence suggesting that circulating tumor DNA has potential clinical applications in the management of patients with early stage and locally advanced NSCLC.
[Nature Reviews Clinical Oncology]
Abstract